3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
3
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Adenocarcinoma
1
Interventions
Radiotherapy
41
Cisplatin
36
Fluorouracil
17
Paclitaxel
15
Docetaxel
14
Cyclophosphamide
14
Carboplatin
14
Filgrastim
13
Doxorubicin
13
Gemcitabine
11
Etoposide
11
Capecitabine
10
Surgical Procedures, Operative
9
Methotrexate
9
Leucovorin
9
Chemotherapy, Adjuvant
9
Vincristine
8
Peripheral Blood Stem Cell Transplantation
8
Oxaliplatin
8
Dexamethasone
7
Bevacizumab
7
Topotecan
6
Radiotherapy, Conformal
6
Prednisone
6
Fenretinide
6
Cetuximab
6
Neoadjuvant Therapy
5
Mitomycin
5
Irinotecan
5
Ifosfamide
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
NETWORK
×
Pancreaticoduodenectomy
×
Clear all
NCT01419002
2015-07-29
Net-Pac
CHIR-Net
Phase 3
Terminated
5 enrolled